Valuation: EMV Capital plc

Capitalization 12.79M 15.97M 15.19M 14.45M 22.89M 1.38B 25.26M 174M 64M 570M 59.85M 58.67M 2.49B P/E ratio 2024 *
-
P/E ratio 2025 * -
Enterprise value -276M -345M -328M -312M -494M -29.73B -546M -3.76B -1.38B -12.31B -1.29B -1.27B -53.7B EV / Sales 2024 *
-0.1x
EV / Sales 2025 * -0.47x
Free-Float
50.24%
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.87%
1 week-3.67%
Current month+8.02%
1 month+9.15%
3 months+1.94%
6 months-23.91%
Current year+8.02%
More quotes
1 week
52.00
Extreme 52
56.00
1 month
46.80
Extreme 46.8
57.90
Current year
48.00
Extreme 48
57.90
1 year
43.00
Extreme 43
80.50
3 years
42.22
Extreme 42.22
95.90
5 years
9.75
Extreme 9.75
210.00
10 years
9.75
Extreme 9.75
2 150.00
More quotes
Director TitleAgeSince
Chief Executive Officer 49 2020-04-30
Director of Finance/CFO - 2020-04-29
General Counsel - 2022-06-06
Manager TitleAgeSince
Director/Board Member 49 2019-10-13
Director/Board Member - 2022-12-08
Chairman 60 2023-01-31
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-1.87%-3.67%-13.22%-36.36%15.97M
+0.12%+0.36%+72.85%+60.08%5.29B
+0.72%+1.59%+21.57%+24.51%3.49B
+1.15%+6.24%+8.49%-29.89%1.45B
0.00%0.00%-33.08%-54.92%906M
+1.63%+5.24%+16.67%-58.19%710M
+0.17%+0.53%+2.87%-7.72%612M
0.00%0.00%-8.24%-3.63%493M
+2.18%-6.13%+26.69%+2.46%409M
0.00%0.00%-2.60%-6.83%281M
Average +0.41%+0.66%+9.20%-11.05% 1.37B
Weighted average by Cap. +0.51%+1.39%+33.86%+19.09%
See all sector performances

Financials

2024 *2025 *
Net sales 2.77B 3.46B 3.29B 3.13B 4.96B 298B 5.47B 37.73B 13.86B 123B 12.96B 12.7B 538B 3.46B 4.33B 4.12B 3.92B 6.2B 373B 6.84B 47.21B 17.34B 154B 16.22B 15.9B 674B
Net income - -
Net Debt -289M -361M -343M -327M -517M -31.1B -571M -3.94B -1.45B -12.88B -1.35B -1.33B -56.18B -1.63B -2.04B -1.94B -1.85B -2.92B -176B -3.23B -22.25B -8.17B -72.77B -7.64B -7.49B -318B
More financial data * Estimated data
Logo EMV Capital plc
EMV Capital plc, formerly NetScientific plc, is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It employs a capital-light investment approach, making use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital Partners Limited. It secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a structure that can support a large portfolio. It develops customized, proactive investment strategies for its subsidiaries and portfolio companies. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its subsidiaries include Glycotest, Inc., and ProAxsis Limited, among others.
Employees
29
More about the company
Date Price Change Volume
25-01-24 52.50 p -1.87% 11,035
25-01-23 53.50 p 0.00% 7,406
25-01-22 53.50 p -1.83% 21,633
25-01-21 54.50 p 0.00% 26,195
25-01-20 54.50 p 0.00% 29,113

Delayed Quote London S.E., January 24, 2025 at 11:35 am EST

More quotes
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.5250GBP
Average target price
1.490GBP
Spread / Average Target
+183.81%
Consensus

Annual profits - Rate of surprise